News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
-content.tmb-hbmobile.jpg?Culture=en&sfvrsn=fec93f9d_2 "Dispensing medicines for a clinical trial (Jan Chlebik for the ICR, 2014) content")
ASCO 2017: Ovarian cancer drug delivers ‘very promising’ results in early trial
A new targeted treatment for ovarian cancer has shown ‘very promising’ results in an early clinical trial – shrinking tumours in half of women with the disease.
Pioneering genetic research into myeloma is spearheading our search for new treatments
Our researchers are pioneering a new understanding of the genetic complexities of myeloma and the innovative use of existing drugs as treatments, as Conor McKeever finds out.
New genetic cause of kidney cancer in children discovered
Scientists have identified a new genetic cause of a childhood kidney cancer called Wilms tumour – revealing insights into how loss of control of chromosome number can lead to cancer.
New benchmarking resource for tricky type of gene mutation
Researchers have made available a vital resource that will allow labs throughout the world to assess how accurately they are detecting an important type of mutation.
Study suggests new approach to assess patients’ cancer genetics
Scientists have used mathematics to predict how many biopsy samples need to be taken from a patient to give an accurate picture of the genetic make-up of their cancer.
‘Free-breathing’ MRI scan is accurate enough for clinical trials
A magnetic resonance imaging (MRI) technique that can measure tumours in the body could be an easy and reliable way to assess lung cancer’s response to treatment, a new study shows.
Potent targeted cancer drug shows promise in first patient trials
An experimental cancer drug which targets cancer cells’ DNA repair could be an effective treatment for a range of cancers, the first clinical trial in patients has shown.
Scientists build molecule to disrupt cancer protein
Researchers have designed and built a molecule that blocks the action of a protein linked to tumour development.
Record-breaking Christmas appeal raises over £100,000
Our 2016 Christmas appeal raised a record-breaking £100,000, giving a huge boost to two of our research projects into breast cancer and sarcoma.
Scientists ‘carbon date’ cancer and unearth secrets about what could help make it deadly
Scientists have put precise timings on the history of a patient’s cancer for the first time, effectively ‘carbon dating’ the different stages in the disease’s progression.
Parkinson’s gene mutation discovered in one third of cancers
A gene found in a hereditary form of Parkinson’s disease is mutated in a third of all human cancers – and helps regulate one of the disease’s most commonly activated cell signalling mechanisms, a new study reveals.
ICR’s Professor Richard Houlston made Fellow of the Royal Society
Professor Richard Houlston, a world-leading geneticist at the ICR, has been elected as a Fellow of the Royal Society in recognition of his outstanding contribution to cancer research.
